Orange Book product · Generic (ANDA)
BUPROPION HYDROCHLORIDE
BUPROPION HYDROCHLORIDE
At a glance
Jul 23, 2018
Approved
Generic (ANDA)
Application
AB3
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 23, 2018
8 yr ago
Today
Pharmaceutical detail
Active ingredient
BUPROPION HYDROCHLORIDE
Strength
150MG
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB3
Application
ANDA 201567
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BUPROPION HYDROCHLORIDE
- 2026BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 220529 · YICHANG HUMANWELL
- 2025BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 217898 · ANNORA PHARMA
- 2025BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 207874 · IPCA LABS LTD
- 2024BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 218385 · GRANULES
- 2023BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 216800 · ANNORA PHARMA
- 2023BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 216766 · YICHANG HUMANWELL
- 2022BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 215568 · GRANULES
- 2020BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 203650 · SUN PHARM
- 2020BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 200216 · SUN PHARM
- 2019BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 211020 · GRAVITI PHARMS
- 2018BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 210497 · ACCORD HLTHCARE
- 2018BUPROPION HYDROCHLORIDEGeneric (ANDA)
ANDA 211347 · YICHANG HUMANWELL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
